https://www.who.int/health-topics/obesity. Accessed August 13, 2023.

Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960–1962 through 2017–2018. NCHS Health E-Stats, Centers for Disease Control and Prevention. 2020. Updated February 8, 2021. Accessed January 29, 2021. https://www.cdc.gov/nchs/data/hestat/obesity-adult-17-18/obesity-adult.htm.

WHO EUROPEAN REGIONAL OBESITY REPORT 2022. ISBN: 978–92–890–5773–8. World Health Organization 2022. https://www.who.int/europe/publications/i/item/9789289057738.

• Adult overweight causes and consequences. Centers for Disease Control and Prevention. Updated March 22, 2021. Accessed January 29, 2021. www.cdc.gov/obesity/basics/causes.html. A systhematic review with a new insight on overweight/obesity.

Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64. https://doi.org/10.1053/j.gastro.2020.01.052.

Article  PubMed  CAS  Google Scholar 

• Vekic J, Stefanovic A, Zeljkovic A. Obesity and Dyslipidemia: A Review of Current Evidence. Curr Obes Rep. 2023. https://doi.org/10.1007/s13679-023-00518-z. A systhematic review with a new insight on atherogenic dyslipidemia and obesity.

Article  PubMed  Google Scholar 

Xiao C, Dash S, Morgantini C, Hegele RA, Lewis GF. Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol. Diabetes. 2016;65:1767–78. https://doi.org/10.2337/db16-0046.

Article  PubMed  CAS  Google Scholar 

Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595–600. https://doi.org/10.1210/jc.2004-0372.

Article  PubMed  CAS  Google Scholar 

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KI, Fruchart JK, James WPT, Loria CM, SmithJr SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5. https://doi.org/10.1161/CIRCULATIONAHA.109.192644.

Article  PubMed  CAS  Google Scholar 

Cornier MA. A Review of Current Guidelines for the Treatment of Obesity. Am J Manag Care. 2022;28(suppl 15):S288–96. https://doi.org/10.37765/ajmc.2022.89292.

Article  PubMed  Google Scholar 

Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1–203. https://doi.org/10.4158/EP161365.GL.

Article  PubMed  Google Scholar 

Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, BerryJD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, de LemosJA. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2013:21(9):E439–47. https://doi.org/10.1002/oby.20135.

Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology Genetics, and Biology. Circ Res. 2016;18(4):547–63. https://doi.org/10.1161/CIRCRESAHA.115.306249.

Article  CAS  Google Scholar 

• Balling M, Afzal S, Smith SD, Varbo A, Langsted A, Kamstrup PR, Nordestgaard BG. Elevated LDL Triglycerides and Atherosclerotic Risk. Am Coll Cardiol. 2023;81(2):136–52. https://doi.org/10.1016/j.jacc.2022.10.019. Important notes on LDL-TG.

Article  CAS  Google Scholar 

• Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. European Heart J. 2021;42:3227–337. https://doi.org/10.1093/eurheartj/ehab484. The newest cardiovascular prevention guidelines.

Arnett D, Blumenthal R, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Dennison Himmelfarb C, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2019;74(10):e177–232. https://doi.org/10.1016/j.jacc.2019.03.010.

Article  PubMed  PubMed Central  Google Scholar 

Petridou A, Siopi A, Mougios V. Exercise in the management of obesity. Metabolism. 2019;92:163–9. https://doi.org/10.1016/j.metabol.2018.10.009.

Article  PubMed  CAS  Google Scholar 

Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of physical activity on cardiovascular disease. Am J Cardiol. 2012;109:288–95. https://doi.org/10.1016/j.amjcard.2011.08.042.

Article  PubMed  Google Scholar 

Sarzynski MA, Burton J, Rankinen T, Blair SN, Church TS, Despres JP, Hagberg JM, Landers-Ramos R, Leon AS, Mikus CR, Rao DC, Seip RL, Skinner JS, Slentz CA, Thompson PD, Wilund KR, Kraus WE, Bouchard C. The effects of exercise on the lipoprotein subclass profile: A meta-analysis of 10 interventions. Atherosclerosis. 2015;243:364–72. https://doi.org/10.1016/j.atherosclerosis.2015.10.018.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Doewes RI, Gharibian G, Zadeh FA, Zaman BA, Vahdat S, Akhavan-Sigari R. An Updated Systematic Review on the Effects of Aerobic Exercise on Human Blood Lipid Profile. Curr Probl Cardiol. 2023;48(5):101108. https://doi.org/10.1016/j.cpcardiol.2022.101108.

Article  PubMed  Google Scholar 

Kraus WE, Powell KE, Haskell WL, Janz KF, Campbell WW, Jakicic JM, Troiano RP, Sprow K, Torres A, Piercy KL. 2018 Physical Activity Guidelines Advisory Committee. Physical Activity, All-Cause and Cardiovascular Mortality, and Cardiovascular Disease. Med Sci Sports Exerc. 2019;51:1270–81. https://doi.org/10.1249/MSS.0000000000001939.

Hasan B, Nayfeh T, Alzuabi M, Wang Z, Kuchkuntla AR, Prokop LJ, Newman CB, Murad MH, Rajjo TI. Weight Loss and Serum Lipids in Overweight and Obese Adults: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2020;105(12):dgaa673. https://doi.org/10.1210/clinem/dgaa673.

Feingold KR, Anawalt B, Blackman MR, et al. editors. South Dartmouth (MA): MDText.com, Inc. 2000.

Sacks FM, Bray GA, Carey VJ, Smith SR, Ryan DH, Anton SD, McManus K, Champagne CM, Bishop LM, Laranjo N, Leboff MS, Rood JC, de Jonge L, Greenway FL, Loria CM, Obarzanek E, Williamson DA. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360(9):859–73. https://doi.org/10.1056/NEJMoa0804748.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–87. https://doi.org/10.1017/S0007114513000548.

Article  PubMed  CAS  Google Scholar 

Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J. 2016;37(13):1079–81. https://doi.org/10.1093/eurheartj/ehv595.

Article  PubMed  Google Scholar 

Chen M, Li Y, Sun Q, Pan A, Manson JE, Rexrode KM, Willett WC, Rimm EB, Hu FB. Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults. Am J Clin Nutr. 2016;104(5):1209–17. https://doi.org/10.3945/ajcn.116.134460.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Islam MA, Amin MN, Siddiqui SA, Hossain MP, Sultana F, Kabir MR. Trans fatty acids and lipid profile: A serious risk factor to cardiovascular disease, cancer and diabetes. Diabetes Metab Syndr. 2019;13(2):1643–7. https://doi.org/10.1016/j.dsx.2019.03.033.

Article  PubMed  Google Scholar 

• Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), European Heart J. 2020;41(1):111–88. https://doi.org/10.1093/eurheartj/ehz455. The newest guidelines on dyslipidemia.

Sahle BW, Chen W, Rawal LB, Renzaho MN. JAMA Netw Open. 2021;4(4):e217044. https://doi.org/10.1001/jamanetworkopen.2021.7044.

Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2. https://doi.org/10.2337/dc09-1825.

Article  PubMed  PubMed Central  Google Scholar 

Pekgor S, Duran C, Marakoglu K, Solak I, Pekgor A, Eryilmaz MA. The Effects of Smoking Cessation on Visceral Adiposity Index Levels. Niger J Clin Pract. 2018;21(6):743–51. https://doi.org/10.4103/njcp.njcp_245_17.

Article  PubMed  CAS  Google Scholar 

Behl TA, Stamford BA, Moffatt RJ. The Effects of Smoking on the Diagnostic Characteristics of Metabolic Syndrome: A Review. Am J Lifestyle Med. 2022;17(3):397–412. https://doi.org/10.1177/15598276221111046.

Article  PubMed  PubMed Central  Google Scholar 

Heffron SP, Parikh A, Volodarskiy A, Ren-Fielding C, Schwartzbard A, Nicholson J, Bangalore S. Changes in Lipid Profile of Obese Patients Following Contemporary Bariatric Surgery: A Meta-Analysis. Am J Med. 2016;129(9):952–9. https://doi.org/10.1016/j.amjmed.2016.02.004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20:330–42. https://doi.org/10.1038/oby.2011.330.

Article  PubMed  CAS  Google Scholar 

Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:1341–52. https://doi.org/10.1016/S0140-6736(11)60205-5.

Article  PubMed  CAS  Google Scholar 

Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95:297–308. https://doi.org/10.3945/ajcn.111.024927.

Article  PubMed  CAS  Google Scholar 

Sahebkar A, Simental-Mendía LE, Reiner Ž, Kovanen PT, Simental-Mendía M, Bianconi V, Pirro M. Effect of orlistat on plasma lipids and body weight: A systematic review and meta-analysis of 33 randomized controlled trials. Pharmacol Res. 2017;122:53–65. https://doi.org/10.1016/j.phrs.2017.05.022.

Article  PubMed  CAS  Google Scholar 

Nakou ES, Filippatos TD, Georgoula M, Kiortsis DN, Tselepis AD, Mikhailidis DP, Elisaf MS. The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. Curr Med Res Opin. 2008;24:1919–29. https://doi.org/10.1185/03007990802177150.

Article  PubMed  CAS